Industry update tracker: January 2026
Monthly update of company press releases and announcements shaping the real-world evidence and access landscape.
January 2026 marked a busy start to the year for company announcements across real-world data and evidence (RWD/E), health data, analytics, evidence platforms, and the broader access ecosystem. In this new monthly feature, we highlight these developments, enabling our readers to quickly review key launches, funding updates, partnerships, expansions, and product enhancements from the month.
AllyGPO and MiBA launch strategic partnership to bring unprecedented data-driven insights to community oncology
AllyGPO®, a technology-forward oncology drug group purchasing organization, and MiBA (Meaningful Insights Biotech Analytics), a leader in AI-powered oncology analytics, announced a groundbreaking strategic partnership to transform how community oncology practices access and apply RWD. The partnership leverages MiBA's advanced clinical data insights and precision analytics and AllyGPO's practice intelligence center, AllyIQ®, to close long-standing information gaps in oncology care and drive improved outcomes for patients and community practices.
ConcertAI, a leading oncology RWE and RWD and AI SaaS technology company, and Foundation Medicine, a global, patient-focused precision medicine company, announced a collaboration to combine their data assets for life sciences research. The collaboration brings Foundation Medicine’s expansive de-identified multimodal dataset derived from its genomic testing portfolio together with ConcertAI’s high-quality clinical data, to support more efficient drug development and RWE research.
datma and Rhythm Biosciences announce collaboration to apply federated real-world data to genomic diagnostic development
datma, a leader in federated rwd access, and Rhythm Biosciences Ltd, a leading developer in predictive cancer diagnostics technology including its geneType™ risk assessment portfolio, announced an exploratory collaboration to evaluate how datma.FED, datma's federated data platform, could support and accelerate the commercialization of Rhythm's genomic-integrated cancer risk prediction portfolio.
GeneDx and Komodo Health partner to build the world’s most complete longitudinal rare disease dataset
GeneDx, a leader in delivering improved health outcomes through genomic insights, announced a strategic partnership with Komodo Health, the leader in AI-powered healthcare intelligence. Through the partnership, GeneDx’s Infinity™ will leverage real-world patient insights from Komodo’s Healthcare Map®, to create the most comprehensive, longitudinal dataset for rare disease. The collaboration will unlock a new level of visibility into how rare diseases are diagnosed, managed, and treated across the full patient journey.
Helix Announces Multi-Year Strategic Collaboration with GSK to Drive Precision Medicine Development
Helix, the leading enterprise genomics company, announced a multi-year strategic collaboration with GSK. This agreement provides GSK access to Helix's continuously growing, deeply phenotyped GenoSphere™ cohorts that cover a wide range of disease areas. Helix GenoSphere™ cohorts consist of comprehensive Exome+® genomic and rich longitudinal clinical data, enhanced with third party medical, pharmacy, and mortality claims. Designed to accelerate Life Sciences research across the development cycle, these datasets are powered by Helix Research Network®, the largest and fastest growing precision health network in the world.
Navidence raises seed funding from Nina Capital and Grand Ventures to bring clarity to real-world data-driven research
Navidence, a technology company focused on defining health data and supporting researchers in study design, has completed its Series Seed preferred funding round, co-led by Grand Ventures (Grand Rapids, Michigan) and Nina Capital (Barcelona, Spain).
- Learn more about Navidence’s development of computable operational definition (CODef) libraries in our interview with Aaron Kamauu, CEO and co-founder of Navidence.
OneMedNet delivers a real-world data feed of 1.5M patients consisting of 4M encounters
OneMedNet Corporation, a leading provider of regulatory-grade, AI-ready RWD announced that it has successfully delivered an anonymized RWD feed representing 1.5 million patients and 4 million encounters to a premier healthcare data and analytics organization serving top pharmaceutical, biotechnology, and medical device companies.
Oracle Life Sciences AI data platform unites data and agentic intelligence to accelerate medical breakthroughs and drive commercial success
Oracle announced Oracle Life Sciences AI Data Platform, a generative AI-enabled solution designed to empower pharmaceutical, medical device, research, and life sciences organizations to accelerate outcomes across R&D, clinical trials, post-market safety, and commercialization.
Peritia launches platform to accelerate life sciences, from product concept to commercialization
Consolidating the legacy brands BioBridges, CHEORS, and Monitorforhire into Peritia creates a single partner offering end-to-end support across service lines that span corporate and product strategy, operational execution, and value, evidence, and access, reflecting how leading life sciences organizations manage the full product lifecycle.
Ro announces research collaboration to better understand and improve the real-world patient experience with GLP-1s
Ro, the leading direct-to-patient healthcare company, today announced a research collaboration with Amgen to study barriers to care and patients' treatment experience. Powered by data from Ro's nationwide platform, the research will evaluate the real-world challenges that patients and providers must navigate in order to access and deliver evidence-based obesity care.
Thermo Fisher Scientific, Inc., the world leader in serving science, announced the enrollment of the first patient in the new PPD™ CorEvitas™ Obesity Registry. This prospective, observational registry will generate RWE on the long-term effectiveness, safety and patient experience associated with obesity management therapies, including anti-obesity medications.
TriNetX unveils conversational AI interface and enhanced API capabilities
TriNetX, driven by its vision of a connected world where data and intelligence power improved human health, announced results demonstrating its TriNetX LIVE™ platform is transforming how pharmaceutical companies design and execute clinical trials. Uniting clinically rich RWD with AI capabilities, the platform has enabled measurable reductions in costly protocol amendments and dramatic improvements in site identification efficiency, results that are now driving the next generation of platform innovation.
Truveta launches real-time clinical trials solution to accelerate study design, enrollment, and evidence generation
Truveta announced the launch of its new clinical trials solution that enables trial sponsors to design, optimize, and execute clinical studies using the most complete, daily refreshed RWD in the US.
- Learn more about Truveta’s new solution in our upcoming webinar
UBC acquires Evidinno Outcomes Research, expanding real-world evidence and HEOR capabilities
United BioSource LLC announced it has acquired Evidinno Outcomes Research, Inc. (Evidinno), a healthcare research consulting firm headquartered in Vancouver, Canada specializing in RWE, epidemiology, evidence synthesis, and advanced statistical and economic analysis.
Verana Health merges with COTA to dramatically expand scale, velocity, and depth of real-world data offerings across oncology and other specialties
Verana Health®, a digital health company dedicated to revolutionizing patient care and clinical research through RWD, has announced a merger with COTA, Inc®. The merger expands the company’s therapeutic offerings in data and software solutions for real-world insights that accelerate clinical research, expedite treatment options, and improve patient care.
Veritas Data Research launches Provider Finder
Veritas Data Research, the leading provider of foundational healthcare datasets, announced the launch of Provider Finder, a high-precision solution designed to identify the specific physicians and facilities where medical care was delivered to patients over the last decade.
| Register for free today to become a member of The Evidence Base and receive the latest news straight to your inbox. |